Old Web
English
Sign In
Acemap
>
Paper
>
A Phase I study of IMCgp100: durable responses with a novel first-in-class immunotherapy for advanced melanoma
A Phase I study of IMCgp100: durable responses with a novel first-in-class immunotherapy for advanced melanoma
2014
Mark R. Middleton
J. Evans
Neil Steven
Pippa Corrie
Clive Mulatero
Mario Sznol
William Shingler
Dominic P. Smethurst
Namir J. Hassan
Yvonne McGrath
Bent K. Jakobsen
Keywords:
Immunotherapy
Cancer research
Immunology
advanced melanoma
phase i study
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]